Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Ana Paula, Fuentes"'
Autor:
Juan Fernando, Gallegos-Orozco, Ana Paula, Fuentes, Marco Antonio, Olivera-Martinez, Gabriela, Gutiérrez-Reyes, Diego, Cortina, Jesús Alberto, Oregel, Christian, Pérez-Pruna, María Sara, Sixtos, Socorro, Cruz-Castellanos, Luis Enrique, Soto-Ramírez, Roberto, Rodríguez-Díaz, Luis, Fuentes-Romero, María Concepción, Gutiérrez-Ruiz, David, Kershenobich
Publikováno v:
Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion. 55(2)
Currently, interferon alfa and ribavirin are the mainstay of therapy for patients with chronic hepatitis C. Recently the pegylation of interferon has allowed a once weekly application, resulting in an increased sustained viral response rate. The anal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0720aed43ce185785cdd3ac5f32287db
https://pubmed.ncbi.nlm.nih.gov/12827916
https://pubmed.ncbi.nlm.nih.gov/12827916
Autor:
Carlos Hinojosa-Becerril, Ana Paula Fuentes, Gabriela Gutierrez-Reyes, Socorro Cruz-Castellanos, Ma. Sara Sixtos-Alonso, Ma Concepción Gutiérrez-Ruiz, Christian Pérez-Pruna, David Kershenobich, Marco Olivera-Martinez, Juan F. Gallegos-Orozco, Juan Gerardo Argueta
Publikováno v:
Archives of medical research. 34(2)
Hepatitis C is a major cause of liver disease worldwide. It has been associated with decreased health-related quality of life (HRQL) and psychiatric symptoms. Our aim was to assess HRQL, depression, and illness understanding in patients with chronic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c70947705ad57b7e173960a966b72c2
https://pubmed.ncbi.nlm.nih.gov/12700008
https://pubmed.ncbi.nlm.nih.gov/12700008